INSIGHTS ON DRUG DEVELOPMENT
-
Bioprocess Optimization: Leveraging Functional DOE With Time-Based Insights
Explore the key differences between traditional DOE and Functional DOE as Seongjin Kim demonstrates how the latter enhances bioprocess optimization through a fed-batch cell culture example.
-
Take Action On PFAS To Protect Your Critical Processes
PFAS restrictions are tightening, but a full ban could disrupt critical industries lacking alternatives, such as pharmaceutical manufacturing. Learn where PFAS use remains indispensable.
-
Formulating Better ASDs And mAbs: Advances In Applied Nanotechnology
Learn about new data on nanotechnology formulations for multiple dose forms and routes of delivery, including oral, long-acting injectables, inhalation, and ophthalmic.
-
Advancements In GLP-1 Analog Formulation: Overcoming Challenges
Oral GLP-1 formulations represent a groundbreaking advance in obesity treatment to offer improved patient comfort and adherence while expanding the therapeutic market.
-
Preclinical Evaluation Of Antifibrotics In COVID-Induced Fibrosis Model6/10/2025
Advancing the development of effective antifibrotic therapies requires urgent investment in clinically relevant, IND-enabling preclinical models to address the growing burden of fibrotic diseases.
-
Futurizing Healthcare By Localizing The Life Sciences12/12/2024
Mustapha Bittaye's journey highlights the importance of international funding in fostering local scientific talent and biopharma resilience, empowering research and manufacturing in developing countries.
-
Nitrosamine Impurities: Are Your Products Compliant?11/6/2023
Potential strategies for vulnerable drug products include shelf-life reduction, investigating nitrite contribution from excipient suppliers, examining formulation processes, and introducing additives.
-
Experimental CCI — Induced Neuropathic Pain Model6/18/2025
Advance neuropathic pain research and therapeutic development with the Chronic Constriction Injury (CCI)-induced neuropathic pain model to uncover mechanisms and evaluate promising candidates.
-
What Are ATMPs And Why Do They Matter?3/28/2025
Delves into the evolution of Advanced Therapy Medicinal Products (ATMPs), exploring their complex development, revolutionary potential in treating diseases, and the intricacies of cell and gene therapies.
DRUG DEVELOPMENT SOLUTIONS
-
Explore end-to-end services offered by a trusted CDMO partner with more than 15 years of industry-leading experience in conjugation and purpose-built manufacturing facilities.
-
Fluorescent Stereo Microscope Leica M165 FC
The Leica M165 FC fully apochromatic corrected stereo microscope with 16.5:1 zoom optics resolves structures down to 1.1 micron for detailed fluorescent imaging.
Image coding allows easy, convenient reproduction of image settings and parameters for fast, consistent, high quality observation and documentation.
TripleBeam technology dedicates a separate beam channel for fluorescence illumination to enhance image contrast, details and intensity for better performance.
-
Explore how a validated diet-induced mouse model that replicates key features of human NASH can support your preclinical research and therapeutic development.
-
Our formulation development and material sciences experts have over 30 years’ experience in pre-formulation and solid state characterization.
-
Gain human-relevant insights with patient-derived assay-ready organoids.